Probiodrug announces appointment of Prof Dr Harald Labischinski and Dr Jonathan David Turner to its Board of Directors

Probiodrug to Present Novel Causative Treatment Approach for Alzheimer’s Disease
Probiodrug to Present Potential New Treatment for Alzheimer’s Disease